The Preparation and Evaluation of Albendazole Microspheres for Colonic Delivery

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2004
Volume 28
Issue 11

Microspheres of Eudragit RL were developed for colonic delivery of albendazole. The effects of polymer concentration, stirring rate, and concentration of emulsifier on particle size and drug loading were studied. A comparative in vitro drug release study of the optimized formulation was carried out.

External Link - article-137427.pdf

Articles in this issue
Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds
The Preparation and Evaluation of Albendazole Microspheres for Colonic Delivery
In the Spotlight-December 2004
In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals
Safety Problems Roil Pharma and FDA
December 2004
Robust CRO Market Is Driving New Merger and Acquisition Activity
The Seventh Annual International Employment Survey
Pharmaco-Fakery
Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Incyte, Genesis Therapeutics to Use AI Platform to Discover Small Molecule Compounds

Patrick Lavery
February 21st 2025
Article

The collaboration will utilize Genesis’ proprietary AI platform, initially focusing on targets selected by Incyte.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Google Launches AI Co-Scientist System

Susan Haigney
February 20th 2025
Article

The AI co-scientist is a multi-agent AI system that can work as a virtual scientific collaborator.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

MMS Acquires Exploristics and Its Flagship Modeling and Simulation Platform

Patrick Lavery
February 14th 2025
Article

In seeking a data-driven approach to efficient drug development, MMS aims to enhance its capabilities in advanced clinical trial design, innovative statistics, and data science with the acquisition.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Axplora Announces €50 Million Investment in GLP-1 Manufacturing in France

Patrick Lavery
February 13th 2025
Article

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.